Disease risk analysis for schizophrenia patients by an automatic AHP framework

Table 3 The final features and related indicators

	Info. gain	Gain ratio	Gini	\({X}^{2}\)	ReliefF	FCBF
Referral times*	0.034	0.024	0.021	2881.741	0.056	0
Drug combination	0.013	0.003	0.008	1037.934	0.112	0
Compliance	0.011	0.026	nan	892.802	0.02	N/A
Adverse reactions times*	0.003	0.005	0.002	339.393	0.001	0
Suggest Referral	0.036	0.07	0.019	168.791	0.038	0.05
Diagnostic type	0.004	0.005	0.003	141.892	0.052	0
Social function	0.006	0.008	0.004	136.586	0.024	0.007
Poverty	0.003	0.003	0.002	129.539	− 0.002	0
Targeted poverty alleviation	0.003	0.003	0.002	129.539	− 0.002	0
Duration days*	0.002	0.001	0.001	85.161	0.02	0
Family guardianship subsidy	0.006	0.01	0.004	60.961	0.006	0
Auxiliary drug combination	0.003	0.001	0.002	59.541	− 0.005	0
Disability rating	0.002	0.001	0.001	38.923	0.128	0
Hospitalization times	0.001	0.001	0.001	36.31	0.027	0
Region	0.063	0.022	0.042	21.243	0.142	0.034
Gender	0	0	0	16.812	0.004	0
Course of disease rating	0.001	0.001	0.001	13.776	0.048	0
Region	0.001	0.002	0	10.812	0.032	0
Drug combination number*	0	0	0	9.131	0.011	0
Age rating	0.001	0.001	0	5.367	0.036	0
Economic status	0	0	nan	2.868	0.068	N/A

ISSN: 1472-6947